Efficacy of indomethacin in in-vitro fertilisation treatment in the modified natural cycle

Not Applicable

Completed

• Conditions: In-vitro fertilisation-treatment in the modified natural cycle, IVF in the natural cycle; Pregnancy and Childbirth; In-vitro fertilisation-treatment

• Registration Number: ISRCTN11805686
• Lead Sponsor: niversity Medical Centre Groningen (UMCG) (The Netherlands)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2007-03-07
• Study Completion: 2007-11-01
• Last Update Posted: 7 September 2021

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 120

Inclusion Criteria

1. Indication for IVF or Intracytoplasmic Sperm Injection (ICSI) treatment
2. Age 18 up to 37 years
3. Ovulatory cycle of 26 to 35 days

Exclusion Criteria

1. Prior IVF or ICSI treatment unless the last treatment was successful
2. Ovarian cysts disabling adequate sonographic assessment of the ovaries
3. Contraindications for indomethacin, such as asthma or prior gastro-intestinal ulcer

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber/percentage of patients per study group that have one or more ovulations prior to follicle aspiration.

Secondary Outcome Measures

Name	Time	Method
umber/percentage of patients per study group that achieve an on-going pregnancy (defined as an intact intra-uterine pregnancy at 12 weeks gestation)